Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab

Shinichiro Kanda; Kazuhiro Hiyama; Izumi Kirino; Yasuo Fukui; Hideo Terashima

doi:10.1002/ccr3.8040

Effective treatment of gallbladder neuroendocrine carcinoma with nivolumab

Clin Case Rep. 2023 Oct 11;11(10):e8040. doi: 10.1002/ccr3.8040. eCollection 2023 Oct.

Authors

Shinichiro Kanda¹, Kazuhiro Hiyama², Izumi Kirino², Yasuo Fukui², Hideo Terashima²

Affiliations

¹ Kochi Medical School (KMS) Kochi University Kochi Japan.
² Department of Surgery Atagi Hospital Kochi Japan.

Abstract

An 89-year-old patient with gallbladder neuroendocrine neoplasms (GB-NENs) and lung cancer metastasis underwent nivolumab monotherapy, resulting in tumor shrinkage. Surgery and adjuvant nivolumab showed efficiency despite low expression of PD-L1.

Keywords: EUS‐FNA; gallbladder NEC; immune checkpoint inhibitors.

Publication types

Case Reports